Lumen Ventures Announces First Closing of Lumen II — CDP Venture Capital and ENPAM Back Italy's Seed Play for Fintech, Insurtech, and Digital Health
TL;DR
Lumen Ventures has announced the first closing of Lumen II, a seed-stage venture capital fund targeting a €100 million hard cap, focused exclusively on insurtech, fintech, digital health, and cybersecurity. Managed by Ulixes Sgr in partnership with Lumen Ventures, the fund has attracted a strong institutional LP base: CDP Venture Capital SGR — Italy's government-backed VC development vehicle — alongside Fondazione ENPAM (the Italian doctors' pension fund) and Banca Popolare di Fondi, supported by a consortium of regional banking institutions. Key Managers are Davide Fioranelli, Luca Adinolfi, and Daniele Vadori. Lumen II positions itself as Italy's dedicated seed platform for the sectors rewriting how financial services, healthcare, and enterprise security are delivered — with a specific mandate to back second-time Italian founders and prioritize gender diversity in portfolio construction.
Key Takeaways
CDP Venture Capital SGR as anchor LP is a high-conviction institutional signal. CDP Venture Capital is not a passive check writer — it is the strategic arm of Italy's Cassa Depositi e Prestiti, deploying capital with an explicit mandate to develop the Italian innovation ecosystem. Its participation in Lumen II's first closing signals that the fund's thesis and team have cleared a rigorous institutional evaluation. For Italian founders, seeing CDP in the cap table is a mark of credibility that opens doors with other institutional players.
Targeting second-time founders and gender diversity is a differentiated sourcing strategy. Most seed funds cast wide nets. Lumen II makes an explicit bet on a specific founder profile: Italian operators who have already been through the build-cycle and are coming back for a second or third venture. These founders arrive with distribution knowledge, customer relationships, and a realistic understanding of how long things take. Pairing that with a diversity mandate means Lumen is fishing in pools that most Italian seed funds systematically overlook.
Insurtech, fintech, digital health, and cybersecurity are defensible, high-conviction verticals in Italy. Italy's financial services infrastructure is underdigitized relative to northern European peers, its healthcare system faces productivity pressures from demographic trends, and its enterprise cybersecurity posture remains behind the curve. These are structural transformation bets in a market of significant scale where early-stage capital has historically been thin.
Ulixes Sgr's management structure adds regulatory infrastructure and institutional credibility. Having Ulixes Sgr — a regulated asset management company within the Banca Popolare di Fondi Group — manage the fund vehicle provides Lumen II with a governance and compliance framework that accelerates institutional LP participation. It separates the investment team's judgment from the fund administration burden, which is the right structure for a specialist seed fund reaching into institutional LP channels.
Why This Fund Matters
Italy's venture capital ecosystem has historically punched below the weight of the underlying economy. The country's GDP is among the largest in Europe, its universities produce world-class engineers and scientists, and its financial services and healthcare sectors are large, complex, and ripe for disruption. Yet institutional seed capital has remained chronically underdeveloped relative to France, Germany, and the Nordics. Lumen II is a deliberate structural response to that gap — a purpose-built seed vehicle focused not on generalist tech but on the four verticals where Italy has both the most obvious transformation potential and the most credible domestic customer base.
The LP composition tells a specific story. CDP Venture Capital SGR exists to build the Italian innovation economy. Its participation signals institutional confidence in both the team's ability to originate quality deal flow and the thesis's alignment with Italy's technology development priorities. Fondazione ENPAM — which manages retirement assets of Italy's medical professionals — bringing capital to a fund with a digital health focus is not accidental; it reflects an awareness that the sector their members work in is about to be transformed by technology, and that getting ahead of that transformation through venture exposure makes strategic sense.
The focus on second-time founders deserves specific credit as a strategic choice. First-time founders in regulated sectors like insurtech and fintech frequently underestimate compliance timelines, enterprise sales cycles, and the capital requirements of building distribution in markets dominated by incumbent institutions. Repeat founders who have navigated those challenges before arrive with a dramatically higher probability of moving through the critical early stages efficiently. Backing this profile at seed, before other investors have priced in the track record, is where Lumen's edge lives.
The cybersecurity inclusion alongside financial and health verticals is also worth noting. As Italy's financial services and healthcare systems digitize, their attack surfaces expand proportionally. The intersection of fintech and cybersecurity, and of digital health and data security, is where some of the most interesting product opportunities are emerging — and where regulatory urgency (NIS2, DORA) is accelerating enterprise purchasing decisions. Lumen's ability to invest across these verticals simultaneously gives it a cross-sector view of where infrastructure gaps are most acute.
The Team
Lumen II is led by three Key Managers operating through the Ulixes Sgr partnership. Davide Fioranelli and Luca Adinolfi anchor the Lumen Ventures investment team, bringing direct operator and investment experience in the Italian technology ecosystem built through the Lumen I portfolio. Daniele Vadori rounds out the management team with over 15 years of experience spanning investment and innovation in Italy's corporate and institutional sectors. The Lumen Ventures approach is explicitly operator-first — the fund's positioning as a "seed stage operator fund" signals a preference for managers who have built products and companies, not just analyzed them. This is the right profile for a fund backing second-time founders: peer credibility matters in deal origination when targeting experienced repeat entrepreneurs who have alternatives for where to take their cap table.
Early Portfolio
Lumen Ventures has deployed capital through Lumen I across a portfolio of companies in insurtech, fintech, and digital health operating in and around the Italian market. While Lumen II portfolio companies are yet to be announced given the early stage of the fund, the team's track record from the first vehicle provides the pattern recognition and LP confidence underpinning the second raise. Portfolio details from Lumen I are available on the firm's website for founders looking to understand the type of companies Lumen backs at seed stage.
What This Means for Founders
If you are building an insurtech, fintech, digital health, or cybersecurity company with a meaningful connection to Italy — either as a headquarters location, as a primary market, or as a strategic anchor for your European expansion — Lumen II is one of the most relevant seed-stage conversations you can have right now. The fund is explicitly designed as a lead investor, meaning it takes the point position on a round and does the work to build the syndicate around it. That is meaningfully different from seed funds that prefer to co-invest alongside others and wait for someone else to set the terms.
The second-time founder focus means Lumen's evaluation lens is calibrated differently from generalist seed investors. Expect questions that probe what you learned from your previous venture, how your current go-to-market reflects that learning, and how you think about regulatory complexity in your sector. If you are a first-time founder building outside these verticals, this is not the right primary lead. But if you are coming back for a second or third venture in a regulated Italian technology sector, Lumen II is one of the most aligned pools of capital in Europe for your profile.
Fund Momentum Take
Lumen II arrives at an interesting inflection point for Italian venture capital. The ecosystem has matured meaningfully — more repeat founders are circulating, more institutional LPs are allocating to Italian VC, and more European corporates are paying attention to Italian innovation as a complement to their broader strategies. A fund with a clear vertical thesis, a differentiated founder profile focus, and the institutional credibility of CDP Venture Capital and ENPAM in its LP stack is well-positioned to attract the right deal flow and co-investors.
The risk profile is inherent to Italian venture more broadly: exit markets remain thinner than in the US or northern Europe, trade sale outcomes are more realistic than IPOs, and the timeline from seed to meaningful liquidity is long. Regulatory complexity in fintech and insurtech is also a genuine operational challenge for portfolio companies — building on Italy's infrastructure requires compliance sophistication that can slow product iteration. These are features of the market, not surprises, and a team with Lumen's sector depth has more tools to help portfolio companies navigate them than a generalist seed fund would.
Our take: the LP composition is the clearest signal here. CDP Venture Capital SGR backing Lumen II is an active endorsement of the team's ability to develop the Italian fintech, insurtech, and digital health ecosystem at seed stage. That endorsement, combined with the fund's focused thesis and operator-first team profile, makes Lumen II one of the more compelling emerging fund stories out of Italy in the current cycle. Fundraising continues toward the €100 million hard cap — meaning the fund is still accessible for LPs looking to gain exposure to Italian sector-specialist venture capital through a team with genuine institutional backing.
Frequently Asked Questions
What sectors does Lumen II invest in?
Lumen II focuses exclusively on seed-stage companies in four verticals: insurtech, fintech, digital health, and cybersecurity. The common thread is regulated sectors in Italy undergoing structural digitization, where technology companies can build durable competitive positions backed by switching costs and regulatory moats.
Who are the anchor LPs in Lumen II's first closing?
The first closing was anchored by CDP Venture Capital SGR (the venture capital arm of Italy's Cassa Depositi e Prestiti), Fondazione ENPAM (the pension foundation for Italian doctors and medical professionals), and Banca Popolare di Fondi, alongside a pool of regional Italian banking institutions.
What is the fund's target size and current fundraising status?
Lumen II has a hard cap target of €100 million. The fund has completed its first closing and is continuing to raise toward the hard cap. The exact amount closed in the first tranche has not been publicly disclosed.
Does Lumen II only invest in Italian companies?
Lumen II primarily invests in Italian-headquartered companies but also considers internationally based companies that have a strong strategic connection to the Italian market — for example, companies targeting Italian enterprise or consumer customers, or those with co-founders or key team members with deep Italian industry relationships.
What is Ulixes Sgr's role in managing Lumen II?
Ulixes Sgr is the licensed Italian asset management company (SGR) that serves as the formal fund manager for Lumen II, providing the regulatory infrastructure and institutional governance framework required under Italian law. It is part of the Banca Popolare di Fondi group. Investment decisions are made by Key Managers Davide Fioranelli, Luca Adinolfi, and Daniele Vadori, operating through the Lumen Ventures and Ulixes Sgr partnership.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.